Screening of cancer predisposition syndromes
© 2021. Crown..
Pediatric patients with cancer predisposition syndromes are at increased risk of developing malignancies compared with their age-matched peers, necessitating regular surveillance. Screening protocols differ among syndromes and are composed of a number of elements, imaging being one. Surveillance can be initiated in infants, children and adolescents with a tumor known or suspected of being related to a cancer predisposition syndrome or where genetic testing identifies a germline pathogenic gene variant in an asymptomatic child. Pre-symptomatic detection of malignant neoplasms offers potential to improve treatment options and survival outcomes, but the benefits and risks of screening need to be weighed, particularly with variable penetrance in many cancer predisposition syndromes. In this review we discuss the benefits and risks of surveillance imaging and the importance of integrating imaging and non-imaging screening elements. We explore the principles of surveillance imaging with particular reference to whole-body MRI, considering the strategies to minimize false-negative and manage false-positive whole-body MRI results, the value of standardized nomenclature when reporting risk stratification to better guide patient management, and the need for timely communication of results to allay anxiety. Cancer predisposition syndrome screening is a multimodality, multidisciplinary and longitudinal process, so developing formalized frameworks for surveillance imaging programs should enhance diagnostic performance while improving the patient experience.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
Pediatric radiology - 52(2022), 2 vom: 01. Feb., Seite 401-417 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Al-Sarhani, Haifa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer predisposition syndrome |
|---|
| Anmerkungen: |
Date Completed 02.02.2022 Date Revised 02.02.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00247-021-05023-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323474861 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323474861 | ||
| 003 | DE-627 | ||
| 005 | 20231225184249.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00247-021-05023-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1078.xml |
| 035 | |a (DE-627)NLM323474861 | ||
| 035 | |a (NLM)33791839 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Al-Sarhani, Haifa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Screening of cancer predisposition syndromes |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.02.2022 | ||
| 500 | |a Date Revised 02.02.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. Crown. | ||
| 520 | |a Pediatric patients with cancer predisposition syndromes are at increased risk of developing malignancies compared with their age-matched peers, necessitating regular surveillance. Screening protocols differ among syndromes and are composed of a number of elements, imaging being one. Surveillance can be initiated in infants, children and adolescents with a tumor known or suspected of being related to a cancer predisposition syndrome or where genetic testing identifies a germline pathogenic gene variant in an asymptomatic child. Pre-symptomatic detection of malignant neoplasms offers potential to improve treatment options and survival outcomes, but the benefits and risks of screening need to be weighed, particularly with variable penetrance in many cancer predisposition syndromes. In this review we discuss the benefits and risks of surveillance imaging and the importance of integrating imaging and non-imaging screening elements. We explore the principles of surveillance imaging with particular reference to whole-body MRI, considering the strategies to minimize false-negative and manage false-positive whole-body MRI results, the value of standardized nomenclature when reporting risk stratification to better guide patient management, and the need for timely communication of results to allay anxiety. Cancer predisposition syndrome screening is a multimodality, multidisciplinary and longitudinal process, so developing formalized frameworks for surveillance imaging programs should enhance diagnostic performance while improving the patient experience | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cancer predisposition syndrome | |
| 650 | 4 | |a Children | |
| 650 | 4 | |a Li–Fraumeni syndrome | |
| 650 | 4 | |a Subsequent malignant neoplasms | |
| 650 | 4 | |a Surveillance imaging | |
| 650 | 4 | |a Whole-body magnetic resonance imaging | |
| 700 | 1 | |a Gottumukkala, Ravi V |e verfasserin |4 aut | |
| 700 | 1 | |a Grasparil, Angelo Don S |c 2nd |e verfasserin |4 aut | |
| 700 | 1 | |a Tung, Eric L |e verfasserin |4 aut | |
| 700 | 1 | |a Gee, Michael S |e verfasserin |4 aut | |
| 700 | 1 | |a Greer, Mary-Louise C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric radiology |d 1973 |g 52(2022), 2 vom: 01. Feb., Seite 401-417 |w (DE-627)NLM000468924 |x 1432-1998 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2022 |g number:2 |g day:01 |g month:02 |g pages:401-417 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00247-021-05023-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2022 |e 2 |b 01 |c 02 |h 401-417 | ||